CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data – Dr Ma, MD Published 2024-01-04 Download video MP4 360p Download video MP4 720p Recommendations 2:04:18 Living with Chronic Lymphocytic Leukemia (CLL): A CALQUENCE™ Connections Virtual Event 18:07 CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD 14:51 CALQUENCE® (acalabrutinib) ELEVATE-TN, incl. High-Risk Subgroups – Dr Abutalib, MD 1:09:24 Chronic Lymphocytic Leukemia During COVID: A Patient Story 16:53 CALQUENCE® (acalabrutinib) Pooled CV Safety Analysis – Dr Pinilla-Ibarz, MD 11:54 CALQUENCE® (acalabrutinib) Perspectives: Dr Alexey Danilov, MD, PhD 16:14 CALQUENCE® (acalabrutinib) Patient Management & Adherence –Bradley, NP 08:28 Sharon's Treatment Story 02:10 How CALQUENCE® (acalabrutinib) Works 11:55 CALQUENCE® (acalabrutinib) Mechanism of Action (MOA): Dr Pearson, MD 27:13 Dr Daniel Landau Presents CALQUENCE Long-Term and Pooled Cardiovascular Safety Data for CLL/SLL 03:48 Cliff’s Story: Living with CLL 31:15 CALQUENCE® (acalabrutinib) Clinical Insights from a Real-World Patient with Treatment Naive CLL 10:46 CALQUENCE® (acalabrutinib) Patient Testimonials: Doreen’s Story 03:30 Dan’s Story: Living with CLL 02:32 Jane’s Story: Caring for Someone Living with CLL 01:01 Focus on the Things You're Loving 10:09 CALQUENCE® (acalabrutinib) Perspectives: Dr. Tara Graff, DO 08:57 CALQUENCE® (acalabrutinib) Perspectives: Dr Andre Goy, MD Similar videos 02:29 The long-term efficacy of acalabrutinib-based regimens in patients with CLL 38:13 Part 3 - Expert guidance on management of CLL patients with Acalabrutinib - Prof. Peter Hillmen, UK More results